These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 19387008)

  • 21. PRR14L mutations are associated with chromosome 22 acquired uniparental disomy, age-related clonal hematopoiesis and myeloid neoplasia.
    Chase A; Pellagatti A; Singh S; Score J; Tapper WJ; Lin F; Hoade Y; Bryant C; Trim N; Yip BH; Zoi K; Rasi C; Forsberg LA; Dumanski JP; Boultwood J; Cross NCP
    Leukemia; 2019 May; 33(5):1184-1194. PubMed ID: 30573780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia.
    Gupta M; Raghavan M; Gale RE; Chelala C; Allen C; Molloy G; Chaplin T; Linch DC; Cazier JB; Young BD
    Genes Chromosomes Cancer; 2008 Sep; 47(9):729-39. PubMed ID: 18506749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uniparental disomy may be associated with microsatellite instability in acute myeloid leukemia (AML) with a normal karyotype.
    Serrano E; Carnicer MJ; Orantes V; Estivill C; Lasa A; Brunet S; Aventín AM; Sierra J; Nomdedéu JF
    Leuk Lymphoma; 2008 Jun; 49(6):1178-83. PubMed ID: 18452069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations of c-Cbl in myeloid malignancies.
    Katzav S; Schmitz ML
    Oncotarget; 2015 May; 6(13):10689-96. PubMed ID: 26028666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies.
    Makishima H; Jankowska AM; Tiu RV; Szpurka H; Sugimoto Y; Hu Z; Saunthararajah Y; Guinta K; Keddache MA; Putnam P; Sekeres MA; Moliterno AR; List AF; McDevitt MA; Maciejewski JP
    Leukemia; 2010 Oct; 24(10):1799-804. PubMed ID: 20724984
    [No Abstract]   [Full Text] [Related]  

  • 26. Acquired uniparental disomy in myeloproliferative neoplasms.
    Score J; Cross NC
    Hematol Oncol Clin North Am; 2012 Oct; 26(5):981-91. PubMed ID: 23009933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of mutations in myeloproliferative neoplasms.
    Levine RL
    Best Pract Res Clin Haematol; 2009 Dec; 22(4):489-94. PubMed ID: 19959098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
    Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
    Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders.
    Jones AV; Kreil S; Zoi K; Waghorn K; Curtis C; Zhang L; Score J; Seear R; Chase AJ; Grand FH; White H; Zoi C; Loukopoulos D; Terpos E; Vervessou EC; Schultheis B; Emig M; Ernst T; Lengfelder E; Hehlmann R; Hochhaus A; Oscier D; Silver RT; Reiter A; Cross NC
    Blood; 2005 Sep; 106(6):2162-8. PubMed ID: 15920007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of JAK2V617F mutation in Jordanian patients with myeloproliferative neoplasms.
    Jaradat SA; Khasawneh R; Kamal N; Matalka I; Al-Bishtawi M; Al-Sweedan S; Ayesh MH
    Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):160-6. PubMed ID: 26256826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia.
    Muramatsu H; Makishima H; Jankowska AM; Cazzolli H; O'Keefe C; Yoshida N; Xu Y; Nishio N; Hama A; Yagasaki H; Takahashi Y; Kato K; Manabe A; Kojima S; Maciejewski JP
    Blood; 2010 Mar; 115(10):1969-75. PubMed ID: 20008299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flt3 inhibitor AC220 is a potent therapy in a mouse model of myeloproliferative disease driven by enhanced wild-type Flt3 signaling.
    Taylor SJ; Dagger SA; Thien CB; Wikstrom ME; Langdon WY
    Blood; 2012 Nov; 120(19):4049-57. PubMed ID: 22990016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant mice.
    Taylor SJ; Thien CB; Dagger SA; Duyvestyn JM; Grove CS; Lee BH; Gilliland DG; Langdon WY
    Exp Hematol; 2015 Mar; 43(3):191-206.e1. PubMed ID: 25534201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia.
    Benton CB; Boddu PC; DiNardo CD; Bose P; Wang F; Assi R; Pemmaraju N; Kc D; Pierce S; Patel K; Konopleva M; Ravandi F; Garcia-Manero G; Kadia TM; Cortes J; Kantarjian HM; Andreeff M; Verstovsek S
    Cancer; 2019 Jun; 125(11):1855-1866. PubMed ID: 30811597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. JAK2 and MPL mutations in myeloproliferative neoplasms.
    Koppikar P; Levine RL
    Acta Haematol; 2008; 119(4):218-25. PubMed ID: 18566540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic relevance of acquired uniparental disomy in serous ovarian cancer.
    Tuna M; Ju Z; Smid M; Amos CI; Mills GB
    Mol Cancer; 2015 Feb; 14(1):29. PubMed ID: 25644622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid identification of heterozygous or homozygous JAK2(V617F) mutations in myeloproliferative neoplasms using melting curve analysis.
    Ho CL; Wu YY; Hung HM; Chang PY; Kao WY; Chen YC; Chao TY
    J Formos Med Assoc; 2012 Jan; 111(1):34-40. PubMed ID: 22333011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
    Meggendorfer M; Bacher U; Alpermann T; Haferlach C; Kern W; Gambacorti-Passerini C; Haferlach T; Schnittger S
    Leukemia; 2013 Sep; 27(9):1852-60. PubMed ID: 23628959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.
    Flotho C; Steinemann D; Mullighan CG; Neale G; Mayer K; Kratz CP; Schlegelberger B; Downing JR; Niemeyer CM
    Oncogene; 2007 Aug; 26(39):5816-21. PubMed ID: 17353900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.